Table 1.

Oligonucleotides used for EMSAs

ZRE	Oligonucleotide
TSA1 ZRE1	5′-ggccCTGTTCTGGCCCGTCGGGTTTTCTGACAAA-3′
	3′-GACAAGACCGGGCAGCCCAAAAGACTGTTTagct-5′
ZRG17 ZRE	5′-ggccACTGAAAATGATGAACCTTGAAGGTATTTTTGTTACT-3′
	3′-TGACTTTTACTACTTGGAACTTCCATAAAAACAATGAagct-5′
ZRG17 m1ZRE	5′-ggccACTGAAAATGATGACAAGGTCCTTGATTTTTGTTACT-3′
	3′-TGACTTTTACTACTGTTCCAGGAACTAAAAACAATGAagct-5′

ZRG17 m1ZRE was mutated such that each position in the potential ZRE was altered by a transversion mutation. ZREs or regions mutated in each complementary oligonucleotide pair are indicated by the underline. The lower-case letters indicate EagI- and SalI-complementary overhangs included for cloning these fragments into a lacZ reporter plasmid for future studies.